Diseases, Conditions, Syndromes

Immunoglobulin clinical trial launched to prevent COVID-19 side effects

The Hospital del Mar Medical Research Institute (IMIM), Hospital del Mar, the University of California-Davis and the University of Texas have launched a clinical trial to analyze how useful a food supplement can be for preventing ...

Cardiology

Synthetic 'mini' receptors block atherosclerosis

Atherosclerosis, a lipid-triggered chronic inflammatory disease of the arteries, is the main cause of strokes and heart attacks. An international team of researchers led by the Technical University of Munich (TUM) and the ...

Diseases, Conditions, Syndromes

New combination therapy offers chance of healing hepatitis B

Around 260 million people, more than three percent of the global population, are chronically infected with the hepatitis B virus (HBV); in the long term, this often leads to complications such as liver cirrhosis and liver ...

Diseases, Conditions, Syndromes

COVID-19 vaccine safe and effective in animal models

Researchers at Yerkes National Primate Research Center, Emory University, have developed a COVID-19 vaccine that has proven safe and effective in mice and monkeys. Results from this National Institute of Allergy and Infectious ...

page 35 from 40